There’s nothing intricate about the current popular tobacco item on the internet: Zyn is a small pouch containing nicotine and flavorings.

However, it has sparked a discussion among government officials, caregivers, and commentators that mirrors a more intricate environment where major tobacco companies vigorously promote substitute goods while analysts struggle with assessing their potential advantages and dangers.

Zyn is available in various flavors such as mint, coffee, and citrus. Philip Morris International promotes it to adult smokers. However, videos of teenagers and young adults using Zyn have gone viral on TikTok and other popular social media sites.

There is concern among supporters of Zyn that its growing popularity may make it appealing to underage adolescents, similar to how Juul caused a significant increase in vaping over several years. However, some experts argue that this risk is offset by the opportunity to persuade adults to quit smoking and using other conventional tobacco products, responsible for 480,000 deaths each year in the United States.

According to Dr. Jasjit Ahluwalia, an addiction expert at Brown University, insanity can be described as continuing to do the same action while anticipating a different outcome. This mirrors what has been happening in regards to tobacco for many years, where the focus has been on complete abstinence instead of considering options that may lessen the harm.

According to Ahluwalia, the use of nicotine pouches and e-cigarettes could potentially assist smokers in reducing or stopping their cigarette consumption.

This method is commonly used in the United Kingdom, but it is not widely accepted in the medical community in the United States. Only medications of pharmaceutical quality, such as nicotine gum and lozenges, are officially authorized to aid in smoking cessation.

Ahluwalia notes that Zyn functions similarly to other products by gradually releasing low amounts of nicotine into the gums in order to decrease cravings. However, the major distinction is that Zyn is being sold by Philip Morris, a major tobacco company and a longstanding adversary of anti-smoking organizations.

The political impact of the debate about Zyn has caused a divide between Democrats and Republicans in Washington, fueling further conflict in the ongoing cultural battle in the nation.

In late January, Senator Charles Schumer, a Democrat from New York, urged regulators to look into Zyn, citing concerns about its popularity among teenagers. Some Republican members of the House subsequently warned their constituents that the government was attempting to prohibit nicotine use, using “Big Brother” as a reference.

Tucker Carlson, a popular conservative commentator and user of Zyn, has weighed in on the controversy, stating that Zyn is not immoral and also promoting its debatable advantages, such as improving male strength and cognitive function.

Zyn users have quickly developed their own online vocabulary, including “zynnies,” “zynner” and “zynsky.”

According to Ollie Ganz, a researcher at Rutgers University specializing in tobacco and nicotine, there is an online subculture centered around Zyn that is predominantly led by young males. However, much of this attention is not directly initiated by the brand itself.

Online videos show young people documenting their first experiences trying Zyn, reviewing different flavor combinations and displaying heaping piles of used canisters.

Kathy Crosby, the CEO of the Truth Initiative, an organization that advocates against tobacco, expressed concern about the increasing number of memes and hashtags related to Zyn that are being shared and accepted on various social media platforms.

Studies indicate that nicotine has the potential to disrupt brain development in teenagers, according to Truth and other organizations.

The responsibility of the Food and Drug Administration is to consider the potential risks of Zyn to children and its potential benefits for adults.

According to a spokesperson from the FDA, the organization is keeping track of underage usage and has observed that 1.5% of students in high school and middle school reported using pouches last year. This percentage is significantly lower than the 10% who reported using e-cigarettes.

The FDA has approved the continued sale of Zyn as they continue to evaluate Philip Morris’ application for marketing, which was submitted in 2020. If the usage among teenagers remains low, the company may receive FDA authorization for certain products, available in a variety of strengths and flavors.

The FDA granted its inaugural reduced risk classification to snus, a type of tobacco pouch widely used in Sweden that has lower amounts of carcinogens compared to cigarettes. According to the FDA, individuals who switch to snus from smoking lower their risks of lung cancer, bronchitis, and other illnesses.

The tobacco leaves commonly found in snus are removed by Zyn, leaving only nicotine. According to Philip Morris, this change makes the product more desirable.

According to company representative Corey Henry, some individuals may hesitate to switch to an oral tobacco product if they see it as similar to traditional chewing tobacco. The acceptability among consumers is a significant aspect of Zyn.

Henry stated that Philip Morris does not utilize online influencers or endorsements to advertise Zyn. The company’s website is only accessible for individuals who are 21 years old and above. According to Henry, the flavors offered, such as cinnamon and peppermint, are recognizable to adults.

Zyn arrived in the American market in 2014, however, there has been a significant increase in sales in the past year, totaling $1.8 billion due to a 60% year-over-year increase in shipments.

During a conference call with retailers in November, a company executive described the growth as “spectacular” and “excellent.”

Joseph Teller, a director for oral tobacco products, expressed surprise at the unforeseen events and stated that he was not aware of anyone who had predicted them.

Zyn promotions emphasize the pouches’ discreet, convenient nature as a “smoke-free,” “spit-free” alternative for smokers “at work” or “on the move.”

However, in order to achieve the company’s intended objective of a “tobacco-free future,” Zyn must facilitate a complete transition from cigarettes to their product, rather than maintaining a rotation between the two.

There is limited information about transitioning, and initial studies indicate that pouches may not be a suitable replacement.

In a study conducted by Ohio State University, it was discovered that individuals who smoke require 30 minutes to an hour to obtain the necessary amount of nicotine from Zyn for their cravings to be alleviated. This is in contrast to cigarettes, which provide the same amount of nicotine and relief within five minutes.

Brittney Keller-Hamilton, the leader of the study, stated that the pouches examined did not seem suitable for smokers, especially those with lower nicotine levels. However, she also mentioned that they did not completely fail.

At present, individuals who smoke and have achieved favorable outcomes with Zyn express their desire for it to remain accessible.

Last spring, 39-year-old Justin Wafer was habitually smoking a pack per day while employed as a bartender in Portland, Oregon. On hectic days, he would also use a vape if he was unable to take a break for a cigarette.

However, when his rechargeable electronic cigarette malfunctioned in May, he opted to experiment with Zyn. Currently, he typically uses a pouch every three to four hours and claims he has refrained from smoking for over nine months.

He explains that, to him, it seems no different than medicinal options such as lozenges or gum. But the main advantage is that it is more accessible and has a more pleasant flavor.

___

The Howard Hughes Medical Institute’s Science and Educational Media Group provides support to the Associated Press Health and Science Department. The AP is solely responsible for all of its content.